Front cover story: Eur. J. Immunol. 11'22
نویسندگان
چکیده
European Journal of ImmunologyVolume 52, Issue 11 Cover PictureFree Access Front cover story: Eur. J. Immunol. 11'22 First published: 03 November 2022 https://doi.org/10.1002/eji.202270110AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text full-text accessPlease review our Terms and Conditions Use check box below share version article.I have read accept the Wiley Online Library UseShareable LinkUse link a this article with your friends colleagues. Learn more.Copy URL Share linkShare onEmailFacebookTwitterLinkedInRedditWechat Graphical Abstract Our front illustration shows images CTLs from Bach2-deficient mice containing greatly enlarged granules. The are taken Barton et al. where authors show that loss transcriptional regulator BACH2 leads generation “super-killer” CTLs. They enhanced cytotoxicity they find in arises both an increase memory CD8+ splenocytes cell intrinsic cytolytic proteins, producing granules generated either naïve or population splenocytes. colours been digitally altered for cover. Volume52, Issue11November RelatedInformation
منابع مشابه
J Immunol
Retinoic acid (RA), a well-known vitamin A metabolite, mediates inhibition of the IL-6driven induction of proinflammatory Th17 cells and promotes anti-inflammatory regulatory T cell generation in the presence of TGF-beta, which is mainly regulated by dendritic cells. To directly address the role of RA in Th17/regulatory T cell generation in vivo, we generated vitamin A-deficient (VAD) mice by c...
متن کاملCover Story and Contents Cover Story
The front cover shows ABB serving the cement manufacturing industry, which it has done since 1961 with turnkey installations, electrical equipment and automation systems. In 1990, ABB recognised the MES (Manufacturing Execution Systems) business area as a natural extension to its technology portfolio. Since then, ABB has provided added value solutions that are independent from the installed pro...
متن کاملCover Story
I am very proud and excited for the future of the Asian Oncology Nursing Society (AONS). The vision over eight years ago of developing an Asian organization has clearly become a reality. I am very grateful to have received a plaque of appreciation from AONS President, Myungsun Yi along with my colleagues Kazuko Onishi from Japan and Pongpak Pittayapan from Thailand. However, I would be remiss i...
متن کاملCover story.
The research process for new drug is complicated, time-consuming, and costly. Thousands of chemical compounds must be made and tested in an effort to find one that can achieve a desirable result. It may take approximately ten years to study and test a new drug before it can be approved for the general public. However, in today's pharmaceutical industry drug delivery has become keys in drug prod...
متن کاملCover Story
Su bj ec t G ra de an d Te ac he rs ' Co m m en ts Jo b G ro w th A W ag es N ee ds Im pr ov em en t; So m e ex tr a te st in g w ou ld he lp Pr op er ty Va lu es A + N ew Co m pa ni es B + In du st ry M ix B From 1999 to 2002, American communities with broadband access did signifi cantly better than those without access does matter to the economy, just as common sense would say it should. .. "...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Immunology
سال: 2022
ISSN: ['1521-4141', '0014-2980']
DOI: https://doi.org/10.1002/eji.202270110